Market Overview

UPDATE: Stifel Initiates Coverage On Applied Genetic Technologies Corporation On Good Market Position

Share:

In a report published Friday, Stifel analyst Stephen Willey initiated coverage on Applied Genetic Technologies Corporation (NASDAQ: AGTC) with a Buy rating and $29.00 price target.

In the report, Stifel noted, “We are initiating coverage of Applied Genetic Technologies Corporation (AGTC) with a Buy rating and a 12-month target price of $29. We believe AGTC is well positioned to capitalize on improving investor sentiment around product development opportunities in the gene therapy space and capable of leveraging its expertise in viral vector design, delivery, and manufacturing to address genetically-based Orphan diseases in ophthalmology and potentially other broader indications (including ex-ophthalmology).

"We believe preclinical and clinical proof-of-concept data generated to date meaningfully increases visibility into the prospect that AGTC's platform will be able to safely deliver on the historically-elusive promise of gene therapy, yielding durable improvements in patient outcomes with just a single administration of a therapeutic gene. We believe the opportunity to realize significant valuation step-ups in conjunction with the numerous high-visibility clinical catalysts lined up over the next 12-plus months creates a compelling risk/reward profile at current levels.”

Applied Genetic Technologies Corporation closed on Thursday at $18.35.

Latest Ratings for AGTC

DateFirmActionFromTo
Sep 2019MaintainsOutperform
Sep 2019UpgradesMarket PerformOutperform
Sep 2019Initiates Coverage OnBuy

View More Analyst Ratings for AGTC
View the Latest Analyst Ratings

Posted-In: Stephen Willey StifelAnalyst Color Initiation Analyst Ratings

 

Related Articles (AGTC)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
MJP MorganMaintains13.0
IPARDA DavidsonMaintains76.0
BSBRUBSUpgrades
TGTMorgan StanleyMaintains130.0
VCMorgan StanleyMaintains52.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Medtronic Offers Update Financing Plans Related to Covidien, Says Remains Committed to Deal

5 More Ways 3D Printing Is Taking Over The World: 3D Systems Corporation, Organovo Holdings & More